Back to Results
First PageMeta Content
Food and Drug Administration / Biomedical Advanced Research and Development Authority / United States Department of Health and Human Services / Vaccination / Pharmaceuticals policy / Pandemic and All Hazards Preparedness Act / Public Readiness and Emergency Preparedness Act / Regulatory requirement / Office of Regulatory Affairs / Health policy / Health / Government


FDA’s Medical Countermeasure Initiative (MCMi)
Add to Reading List

Open Document

File Size: 191,05 KB

Share Result on Facebook

Company

Enhance FDA / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

web/smart / active pharmaceutical ingredient / therapies for radiation sickness /

MedicalCondition

radiation injury / radiation sickness / next‐generation smallpox / pandemic influenza / Acute radiation syndrome / anthrax / infectious disease / influenza / /

MedicalTreatment

radiation / /

Organization

US Department of Health and Human Services / Congress / National Institute of Health / Federal Government / Food and Drug Administration / Biomedical Advanced Research and Development Authority / office of Regulatory Affairs / ASPR Division of International Health Security / FDA / FDA’s office of Counterterrorism and Emerging Threats / Department of Homeland Security / Department of Defense / DoD’s Defense Advanced Research Projects Agency / Public Health and Social Services Emergency Fund / FDA’s MCMi / Steering Committee / Centers for Disease Control and Prevention / /

Person

Obama / /

Position

model development programs / President / Executive / Secretary / HHS Assistant Secretary / legal counsel / /

Product

MCM / doxycycline / Federal Food / MCMs / /

PublishedMedium

Public Law / /

Technology

radiation / smart phone / diagnostic tests / API / platform technologies / in vitro diagnostics / /

URL

http /

SocialTag